Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.

Radford-Smith DE. et al, (2022), Liver international : official journal of the International Association for the Study of the Liver

Correspondence on 'The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease'.

Peters RJR. et al, (2020), Annals of the rheumatic diseases

Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease.

Goodchild G. et al, (2020), Clinical medicine (London, England), 20, e32 - e39

Correction: Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis.

Cargill T. et al, (2019), Clinical and translational gastroenterology, 10

Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis

Cargill T. et al, (2019), Clinical and Translational Gastroenterology, 10, e00020 - e00020

Include forthcoming?